deltatrials
Completed NA NCT00321009

LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin

A Prospective Randomized Trial Comparing Enoxaparin to Warfarin for the Prevention of LV Thrombus Formation After Anterior Wall Myocardial Infarction: A 60 Patient Pilot Study

Sponsor: Corewell Health East

Conditions Acute Myocardial Infarction Coronary Artery Disease
Interventions Enoxaparin
Updated 5 times since 2017 Last updated: May 1, 2006 Started: Mar 31, 2000 Completion: Apr 30, 2004

This NA trial investigates Acute Myocardial Infarction and Coronary Artery Disease and is currently completed. Corewell Health East leads this study, which shows 5 recorded versions since 2000 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Change History

5 versions recorded

  1. Jan 2026 — Present [monthly]

    Completed NA

  2. Sep 2024 — Jan 2026 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  5. Jan 2017 — Jan 2021 [monthly]

    Completed NA

    First recorded

Mar 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Corewell Health East
  • Rhone-Poulenc Rorer
Data source: Corewell Health East

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Denver, United States
  • • Doylestown, United States
  • • Greensboro, United States
  • • Royal Oak, United States
  • • Syracuse, United States
  • • Virginia Beach, United States